Pulse Biosciences, Inc. PLSE Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Pulse Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Pulse Biosciences, Inc.'s operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Pulse Biosciences, Inc.'s operating cash flow?
- Pulse Biosciences, Inc. (PLSE) reported operating cash flow of -$14.6M in Q1 2026.
- How has Pulse Biosciences, Inc.'s operating cash flow changed year-over-year?
- Pulse Biosciences, Inc.'s operating cash flow decreased by 7.9% year-over-year, from -$13.52M to -$14.6M.
- What is the long-term trend for Pulse Biosciences, Inc.'s operating cash flow?
- Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s operating cash flow has grown at a 0.0% compound annual growth rate (CAGR), from -$54.1M to -$54.12M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.